Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study
dc.contributor.author | Dage, Jeffrey L. | |
dc.contributor.author | Eloyan, Ani | |
dc.contributor.author | Thangarajah, Maryanne | |
dc.contributor.author | Hammers, Dustin B. | |
dc.contributor.author | Fagan, Anne M. | |
dc.contributor.author | Gray, Julia D. | |
dc.contributor.author | Schindler, Suzanne E. | |
dc.contributor.author | Snoddy, Casey | |
dc.contributor.author | Nudelman, Kelly N. H. | |
dc.contributor.author | Faber, Kelley M. | |
dc.contributor.author | Foroud, Tatiana | |
dc.contributor.author | Aisen, Paul | |
dc.contributor.author | Griffin, Percy | |
dc.contributor.author | Grinberg, Lea T. | |
dc.contributor.author | Iaccarino, Leonardo | |
dc.contributor.author | Kirby, Kala | |
dc.contributor.author | Kramer, Joel | |
dc.contributor.author | Koeppe, Robert | |
dc.contributor.author | Kukull, Walter A. | |
dc.contributor.author | La Joie, Renaud | |
dc.contributor.author | Mundada, Nidhi S. | |
dc.contributor.author | Murray, Melissa E. | |
dc.contributor.author | Rumbaugh, Malia | |
dc.contributor.author | Soleimani-Meigooni, David N. | |
dc.contributor.author | Toga, Arthur W. | |
dc.contributor.author | Touroutoglou, Alexandra | |
dc.contributor.author | Vemuri, Prashanthi | |
dc.contributor.author | Atri, Alireza | |
dc.contributor.author | Beckett, Laurel A. | |
dc.contributor.author | Day, Gregory S. | |
dc.contributor.author | Graff-Radford, Neill R. | |
dc.contributor.author | Duara, Ranjan | |
dc.contributor.author | Honig, Lawrence S. | |
dc.contributor.author | Jones, David T. | |
dc.contributor.author | Masdeu, Joseph C. | |
dc.contributor.author | Mendez, Mario F. | |
dc.contributor.author | Musiek, Erik | |
dc.contributor.author | Onyike, Chiadi U. | |
dc.contributor.author | Riddle, Meghan | |
dc.contributor.author | Rogalski, Emily | |
dc.contributor.author | Salloway, Stephen | |
dc.contributor.author | Sha, Sharon J. | |
dc.contributor.author | Turner, Raymond S. | |
dc.contributor.author | Wingo, Thomas S. | |
dc.contributor.author | Wolk, David A. | |
dc.contributor.author | Womack, Kyle B. | |
dc.contributor.author | Carrillo, Maria C. | |
dc.contributor.author | Dickerson, Bradford C. | |
dc.contributor.author | Rabinovici, Gil D. | |
dc.contributor.author | Apostolova, Liana G. | |
dc.contributor.author | LEADS Consortium | |
dc.contributor.department | Neurology, School of Medicine | |
dc.date.accessioned | 2024-12-12T11:46:55Z | |
dc.date.available | 2024-12-12T11:46:55Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Introduction: One goal of the Longitudinal Early Onset Alzheimer's Disease Study (LEADS) is to define the fluid biomarker characteristics of early-onset Alzheimer's disease (EOAD). Methods: Cerebrospinal fluid (CSF) concentrations of Aβ1-40, Aβ1-42, total tau (tTau), pTau181, VILIP-1, SNAP-25, neurogranin (Ng), neurofilament light chain (NfL), and YKL-40 were measured by immunoassay in 165 LEADS participants. The associations of biomarker concentrations with diagnostic group and standard cognitive tests were evaluated. Results: Biomarkers were correlated with one another. Levels of CSF Aβ42/40, pTau181, tTau, SNAP-25, and Ng in EOAD differed significantly from cognitively normal and early-onset non-AD dementia; NfL, YKL-40, and VILIP-1 did not. Across groups, all biomarkers except SNAP-25 were correlated with cognition. Within the EOAD group, Aβ42/40, NfL, Ng, and SNAP-25 were correlated with at least one cognitive measure. Discussion: This study provides a comprehensive analysis of CSF biomarkers in sporadic EOAD that can inform EOAD clinical trial design. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Dage JL, Eloyan A, Thangarajah M, et al. Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. Alzheimers Dement. 2023;19 Suppl 9(Suppl 9):S115-S125. doi:10.1002/alz.13399 | |
dc.identifier.uri | https://hdl.handle.net/1805/44967 | |
dc.language.iso | en_US | |
dc.publisher | Wiley | |
dc.relation.isversionof | 10.1002/alz.13399 | |
dc.relation.journal | Alzheimer’s & Dementia | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Alzheimer's disease | |
dc.subject | Aβ42/40 | |
dc.subject | CSF | |
dc.subject | NfL | |
dc.subject | SNAP-25 | |
dc.subject | VILIP-1 | |
dc.subject | YKL-40 | |
dc.subject | Amyloid | |
dc.subject | Astrogliosis | |
dc.subject | Biomarkers | |
dc.subject | Dementia | |
dc.subject | Neurogranin | |
dc.subject | pTau181 | |
dc.subject | tTau | |
dc.subject | Tau | |
dc.title | Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study | |
dc.type | Article |